FDA Objects To Proximity Of Ferrlecit Reminder And Unbranded Ads
This article was originally published in The Pink Sheet Daily
Executive Summary
A reminder ad for the iron therapy on the back cover of a journal and a "belly band" around the issue with similar presentation elements represent a full product ad, FDA's ad division says. Watson makes an unsubstantiated claim for "easy administration."
You may also be interested in...
Present Serious, Not Common, Risks First, FDA Tells Watson In Letter On Gelnique
"Restroom stall cling" for the urinary incontinence drug used at medical meeting gets notice of violation letter from DDMAC.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.